Skip to main content

Table 4 Multivariable analysis of the factors associated with HCC prevalence in cirrhotic NAFLD

From: Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study

  Cirrhotic NAFLD
Adjusted ORa 95% CI P value
Age > 65 years 2.35 2.05–2.70 < 0.001
Male gender 2.24 1.98–2.53 < 0.001
Non-Hispanic white 0.79 0.66–0.94 0.008
Non-Hispanic black 0.40 0.26–0.61 < 0.001
Hispanic 1.66 1.39–1.99 < 0.001
Diabetes 1.27 1.10–1.46 0.001
Hypertension 0.89 0.75–1.05 0.173
Hyperlipidemia 0.68 0.60–0.77 < 0.001
Obese 1.12 0.98–1.28 0.085
Morbid obese 0.97 0.85–1.11 0.685
Smoker 1.20 1.05–1.38 0.007
Decompensation 2.78 2.44–3.17 < 0.001
High ALT 1.97 1.74–2.24 < 0.001
  1. ALT alanine aminotransferases, CI confidence interval, HCC hepatocellular carcinoma, NAFLD non-alcoholic fatty liver disease, OR odds ratio
  2. aFactors adjusted with age, gender and white race